-
公开(公告)号：US06231734B1
公开(公告)日：2001-05-15
申请号：US09056639
申请日：1998-04-08
申请人： Carsten Plog , Werner Maunz , Ralf Mueller , Wolfgang Schaefer , Armin Kayser , Ralf Moos , Udo Flesch , Ulrich Simon
发明人： Carsten Plog , Werner Maunz , Ralf Mueller , Wolfgang Schaefer , Armin Kayser , Ralf Moos , Udo Flesch , Ulrich Simon
IPC分类号： G01N27407
CPC分类号： G01N27/4074
摘要： A process and apparatus for selective detection of NO in fluid media, particularly exhaust gases of internal-combustion engines. This process comprises the steps of positioning a nitrosonium-conducting solid electrolyte between two porous electrodes, acting upon one of the two electrodes with the NO-containing fluid medium, and measuring a voltage difference between the two electrodes as an indication of the NO-concentration in the NO-containing fluid medium.
摘要翻译： 用于选择性地检测流体介质中的NO，特别是内燃机的废气的方法和装置。 该方法包括以下步骤：在两个多孔电极之间放置亚硝鎓导电固体电解质，使用含NO的流体介质作用于两个电极之一，并测量两个电极之间的电压差，作为NO浓度的指示 在含NO的流体介质中。
-
公开(公告)号：US6015483A
公开(公告)日：2000-01-18
申请号：US53517
申请日：1998-04-02
申请人： Carsten Plog , Renato Andorf , Ralf Mueller , Wolfgang Schaefer , Armin Kayser
发明人： Carsten Plog , Renato Andorf , Ralf Mueller , Wolfgang Schaefer , Armin Kayser
CPC分类号： B01D53/326 , F01N3/0892 , F01N3/20 , B01D2257/404 , Y02T10/22
摘要： A process for removing NO from exhaust in which NO-containing exhaust is guided to a first electrode on which the NO is anodically oxidized to NO.sup.+, the NO.sup.+ is subsequently transported through an NO.sup.+ -conducting solid electrolyte to a second electrode on which the NO is cathodically reduced.
摘要翻译： 从排气中除去NO的方法，其中NO含有排气被引导到NO被阳极氧化成NO +的第一电极，NO +随后通过NO +传导固体电解质输送到NO 阴极减少。
-
公开(公告)号：US6144286A
公开(公告)日：2000-11-07
申请号：US295393
申请日：1999-04-21
申请人： Ralf Moos , Marco Fandel , Wolfgang Schaefer
发明人： Ralf Moos , Marco Fandel , Wolfgang Schaefer
CPC分类号： C04B35/4682 , C04B35/4684 , C04B35/47 , H01C7/025 , C04B2235/3206 , C04B2235/3208 , C04B2235/3213 , C04B2235/3225 , C04B2235/3227 , C04B2235/3229 , C04B2235/3239 , C04B2235/3241 , C04B2235/3244 , C04B2235/3251 , C04B2235/3256 , C04B2235/3258 , C04B2235/3262 , C04B2235/3284 , C04B2235/3286 , C04B2235/3287 , C04B2235/3293 , C04B2235/3294 , C04B2235/3418 , C04B2235/447 , Y10T29/49082
摘要： A Positive Temperature Coefficient of Resistance resistor includes a ceramic material of the composition [(Ba.sub.1-e-x Sr.sub.x R.sub.e).sub.1-a M.sub.a ][(Ti.sub.1-b-d N.sub.b Q.sub.d)].sub.c O.sub.3, wherein M is a trivalent or quadrivalent element or a mixture of two or several of these elements; N is a quinquevalent or hexavalent element or a mixture of two or several of these elements; Q is a quadrivalent element or a mixture of two or several of these elements; R is a bivalent element or a mixture of two or several of these elements; and 0.5.ltoreq.x.ltoreq.1, a is 0 or 0.0003.ltoreq.a.ltoreq.0.3, and b is 0 or 0.0003.ltoreq.b.ltoreq.0.3, 0.8.ltoreq.c.ltoreq.1.2, 0.ltoreq.d.ltoreq.0.2, and 0.ltoreq.e.ltoreq.0.2.
摘要翻译： 电阻电阻的正温度系数包括组成[（Ba1-e-xSrxRe）1-aMa] [（Ti1-b-dNbQd）] cO3的陶瓷材料，其中M是三价或四价元素或两者的混合物 或这些元素中的几个; N是一种五价或六价元素或两种或几种这些元素的混合物; Q是四价元素或两种或几种这些元素的混合物; R是这些元素的二价元素或两种或几种的混合物; 和0.5≤x≤1，a为0或0.0003
-
公开(公告)号：US08945552B2
公开(公告)日：2015-02-03
申请号：US13071127
申请日：2011-03-24
申请人： Monika Baehner , Sabine Imhof-Jung , Anita Kavlie , Hubert Kettenberger , Christian Klein , Joerg Thomas , Wolfgang Schaefer , Kay-Gunnar Stubenrauch , Markus Thomas
发明人： Monika Baehner , Sabine Imhof-Jung , Anita Kavlie , Hubert Kettenberger , Christian Klein , Joerg Thomas , Wolfgang Schaefer , Kay-Gunnar Stubenrauch , Markus Thomas
IPC分类号： A61K39/395 , C07K16/22 , A61K39/00
CPC分类号： C07K16/22 , A61K2039/505 , C07K16/3015 , C07K16/3046 , C07K16/468 , C07K2317/31 , C07K2317/35 , C07K2317/52 , C07K2317/522 , C07K2317/56 , C07K2317/66 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要： The present invention relates to bispecific, bivalent antibodies against human vascular endothelial growth factor (VEGF/VEGF-A) and against human angiopoietin-2 (ANG-2), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.
摘要翻译： 本发明涉及针对人血管内皮生长因子（VEGF / VEGF-A）和针对人血管生成素-2（ANG-2）的双特异性二价抗体，其生产方法，含有所述抗体的药物组合物及其用途。
-
5.发明授权UV-curing glass printing ink and UV-curing glass printing lacquer and process for printing glass substrates 有权UV固化玻璃印刷油墨和UV固化玻璃印刷漆和印刷玻璃基板的工艺公开(公告)号：US08835530B2
公开(公告)日：2014-09-16
申请号：US11649728
申请日：2007-01-04
CPC分类号： C09D11/101 , C03C17/326
摘要： A glass printing ink and glass printing lacquer are prepared, which contain at least one photoinitiator, at least one resin and at least one additional substance. The resin is an epoxy resin based on bisphenol A, diluted in a UV-curing monomer, or a resin with functional groups containing free functional amino, hydroxy, epoxy, acid, acid anhydride and/or acrylate groups, or a combination of the epoxy resin with the resin with functional groups. The at least one additional substance is a wax. The use of the glass printing ink and glass printing lacquer in printing a glass substrate and processes for the printing of a glass substrate are also described.
摘要翻译： 制备玻璃印刷油墨和玻璃印刷漆，其含有至少一种光引发剂，至少一种树脂和至少一种另外的物质。 树脂是基于双酚A的环氧树脂，其在UV固化单体中稀释，或具有含有游离官能氨基，羟基，环氧，酸，酸酐和/或丙烯酸酯基团的官能团的树脂，或环氧树脂 树脂与树脂与官能团。 至少一种另外的物质是蜡。 还描述了在印刷玻璃基板中使用玻璃印刷油墨和玻璃印刷漆以及印刷玻璃基板的方法。
-
![7H-pyrido[3,4-D]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors](/abs-image/US/2011/11/15/US08058283B2/abs.jpg.150x150.jpg)
6.发明授权7H-pyrido[3,4-D]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors 失效7H-吡啶并[3,4-D]嘧啶-8-酮，其制备和用作蛋白激酶抑制剂公开(公告)号：US08058283B2
公开(公告)日：2011-11-15
申请号：US12087420
申请日：2007-01-29
申请人： Konrad Honold , Jane Paul , Carl Roeschlaub , Wolfgang Schaefer , Stefan Scheiblich , Thomas Von Hirschheydt , Alan Whittle
发明人： Konrad Honold , Jane Paul , Carl Roeschlaub , Wolfgang Schaefer , Stefan Scheiblich , Thomas Von Hirschheydt , Alan Whittle
IPC分类号： C07D471/04 , A61K31/519 , A61P29/00 , A61P35/00 , A61P5/22 , A61P37/00 , A61P25/00
CPC分类号： C07D471/04
摘要： Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above compounds, medicaments containing them and their manufacture, as well as the use of the above compounds in the control or prevention of illnesses such as cancer.
摘要翻译： 本发明的目的是式I化合物，其药学上可接受的盐，对映体形式，非对映异构体和外消旋体，上述化合物的制备，含有它们的药物及其制备，以及上述化合物在对照或 预防癌症等疾病。
-
公开(公告)号：US20100254988A1
公开(公告)日：2010-10-07
申请号：US12753141
申请日：2010-04-02
申请人： Birgit Bossenmaier , Ulrich Brinkmann , Christian Klein , Gerhard Niederfellner , Wolfgang Schaefer , Juergen Michael Schanzer , Claudio Sustmann , Pablo Umana
发明人： Birgit Bossenmaier , Ulrich Brinkmann , Christian Klein , Gerhard Niederfellner , Wolfgang Schaefer , Juergen Michael Schanzer , Claudio Sustmann , Pablo Umana
IPC分类号： A61K39/395 , C07K16/28 , C07H21/04 , A61P35/00
CPC分类号： C07K16/468 , A61K2039/505 , C07K16/2863 , C07K16/32 , C07K2317/24 , C07K2317/31 , C07K2317/41 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/622 , C07K2317/73 , C07K2317/76 , C07K2317/77 , C07K2317/92 , C07K2319/00
摘要： The present invention relates to bispecific antibodies against human ErbB-2 and against human c-Met, methods for their production, pharmaceutical compositions containing the antibodies, and uses thereof.
摘要翻译： 本发明涉及针对人ErbB-2和针对人c-Met的双特异性抗体，其制备方法，含有抗体的药物组合物及其用途。
-
8.发明授权Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agents 失效杂环氨基甲酸酯衍生物，其制造和用作药剂公开(公告)号：US07786113B2
公开(公告)日：2010-08-31
申请号：US11793750
申请日：2005-12-22
IPC分类号： A61K31/5377 , A61K31/44 , C07D413/14 , C07D471/02
CPC分类号： C07D471/04
摘要： Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
摘要翻译： 本发明的目的是式I化合物，其药学上可接受的盐，对映体形式，非对映异构体和外消旋物，上述化合物的制备，含有它们的药物及其制备，以及上述化合物 控制或预防癌症等疾病。
-
公开(公告)号：US20100041684A1
公开(公告)日：2010-02-18
申请号：US12444592
申请日：2007-12-19
申请人： Guy Georges , Matthias Koerner , Irene Kolm , Ulrike Reiff , Wolfgang Schaefer , Edgar Voss , Stefan Weigand
发明人： Guy Georges , Matthias Koerner , Irene Kolm , Ulrike Reiff , Wolfgang Schaefer , Edgar Voss , Stefan Weigand
IPC分类号： A61K31/505 , C07D239/47 , C07D239/56
CPC分类号： C07D239/47 , C07D405/12
摘要： Objects of the present invention are the compounds of formula (I), their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above compounds, medicaments containing them and their manufacture, as well as the use of the above compounds in the control or prevention of illnesses such as cancer.
摘要翻译： 本发明的目的是式（I）的化合物，其药学上可接受的盐，对映体形式，非对映异构体和外消旋体，上述化合物的制备，含有它们的药物及其制备，以及上述化合物在 控制或预防癌症等疾病。
-
![6-(2-ALKYL-PHENYL)-PYRIDO[2,3-D]PYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS](/abs-image/US/2009/10/01/US20090247518A1/abs.jpg.150x150.jpg)
10.发明申请6-(2-ALKYL-PHENYL)-PYRIDO[2,3-D]PYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS 审中-公开用作蛋白激酶抑制剂的6-（2-烷基 - 苯基） - 吡咯并[2,3-D]嘧啶公开(公告)号：US20090247518A1
公开(公告)日：2009-10-01
申请号：US12411778
申请日：2009-03-26
IPC分类号： A61K31/5377 , C07D471/04 , A61K31/519 , A61P35/00
CPC分类号： C07D471/04
摘要： Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
摘要翻译： 本发明的目的是式I化合物，其药学上可接受的盐，对映体形式，非对映异构体和外消旋物，上述化合物的制备，含有它们的药物及其制备，以及上述化合物 控制或预防癌症等疾病。
-
-
-
-
-
-
-
-
-
搜索结果
101 条记录 (耗时 0.049 秒)
